Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Signs and Symptoms × Clear all

Phase

Phase NA 8 Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 518 Neoplasms 264 Carcinoma, Non-Small-Cell Lung 239 Prostatic Neoplasms 238 Colorectal Neoplasms 184 Multiple Myeloma 160 Neoplasm Metastasis 126 Lung Neoplasms 125 Leukemia, Myeloid, Acute 106 Leukemia 103 Lymphoma 102 Lymphoma, Follicular 98 Stomach Neoplasms 90 Lymphoma, Non-Hodgkin 90 Ovarian Neoplasms 84 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Rectal Neoplasms 81 Head and Neck Neoplasms 80 Colonic Neoplasms 80 Uterine Cervical Neoplasms 79 Carcinoma, Hepatocellular 78 Pain 77 Pancreatic Neoplasms 75 Leukemia, Lymphocytic, Chronic, B-Cell 75 Melanoma 69 Papillomavirus Infections 62 Lymphoma, Large B-Cell, Diffuse 59 Recurrence 57 Squamous Cell Carcinoma of Head and Neck 56 Brain Neoplasms 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00194493 2015-05-04

ESRA-C

Dana-Farber Cancer Institute

Phase 3 Completed

Neoplasms, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡